메뉴 건너뛰기




Volumn 37, Issue 4, 2012, Pages 325-331

Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy

Author keywords

11C choline PET CT; biochemical failure; prostate cancer; PSA doubling time; PSA velocity

Indexed keywords

CHOLINE C 11; PROSTATE SPECIFIC ANTIGEN;

EID: 84858129122     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e31823363b0     Document Type: Article
Times cited : (42)

References (30)
  • 1
    • 0033935812 scopus 로고    scopus 로고
    • Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: Continued risk of biochemical failure after 5 years
    • Amling CL, Blute ML, Bergstralh EJ, et al. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. J Urol. 2000;164:101-105. (Pubitemid 30434268)
    • (2000) Journal of Urology , vol.164 , Issue.1 , pp. 101-105
    • Amling, C.L.1    Blute, M.L.2    Bergstralh, E.J.3    Seay, T.M.4    Slezak, J.5    Zincke, H.6
  • 3
    • 0030815150 scopus 로고    scopus 로고
    • Recurrence patterns after radical retropubic prostatectomy: Clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen
    • DOI 10.1016/S0022-5347(01)64238-1
    • Patel A, Dorey F, Franklin J, et al. Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen. J Urol. 1997;158:1441-1445. (Pubitemid 27391215)
    • (1997) Journal of Urology , vol.158 , Issue.4 , pp. 1441-1445
    • Patel, A.1    Dorey, F.2    Franklin, J.3    Dekernion, J.B.4
  • 5
    • 24944504498 scopus 로고    scopus 로고
    • Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy
    • Patel DA, Presti JC Jr, McNeal JE, et al. Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy. J Clin Oncol. 2005;23:6157-6162.
    • (2005) J Clin Oncol , vol.23 , pp. 6157-6162
    • Patel, D.A.1    Presti Jr., J.C.2    McNeal, J.E.3
  • 6
    • 22844433445 scopus 로고    scopus 로고
    • Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy
    • DOI 10.1001/jama.294.4.440
    • DAmico AV, Renshaw AA, Sussman B, et al. Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy. JAMA. 2005;294:440-447. (Pubitemid 41124176)
    • (2005) Journal of the American Medical Association , vol.294 , Issue.4 , pp. 440-447
    • D'Amico, A.V.1    Renshaw, A.A.2    Sussman, B.3    Chen, M.-H.4
  • 8
    • 33645835922 scopus 로고    scopus 로고
    • Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: Meaningful at PSA < 5 ng/ml?
    • DOI 10.1007/s11307-005-0023-2
    • Heinisch M, Dirisamer A, Loidl W, et al. Positron emission tomography/ computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA <5 ng/mL? Mol Imaging Biol. 2006;8:43-48. (Pubitemid 44193401)
    • (2006) Molecular Imaging and Biology , vol.8 , Issue.1 , pp. 43-48
    • Heinisch, M.1    Dirisamer, A.2    Loidl, W.3    Stoiber, F.4    Gruy, B.5    Haim, S.6    Langsteger, W.7
  • 11
    • 69449087191 scopus 로고    scopus 로고
    • Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy
    • Castellucci P, Fuccio C, Nanni C, et al. Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy. J Nucl Med. 2009;50:1394-1400.
    • (2009) J Nucl Med , vol.50 , pp. 1394-1400
    • Castellucci, P.1    Fuccio, C.2    Nanni, C.3
  • 12
    • 77749249079 scopus 로고    scopus 로고
    • Predictive factors of [(11)C] choline PET/CT in patients with biochemical failure after radical prostatectomy
    • Giovacchini G, Picchio M, Coradeschi E, et al. Predictive factors of [(11)C] choline PET/CT in patients with biochemical failure after radical prostatectomy. Eur J Nucl Med Mol Imaging. 2010;37:301-309.
    • (2010) Eur J Nucl Med Mol Imaging. , vol.37 , pp. 301-309
    • Giovacchini, G.1    Picchio, M.2    Coradeschi, E.3
  • 13
    • 77954887685 scopus 로고    scopus 로고
    • PSA doubling time for prediction of [(11)C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy
    • Giovacchini G, Picchio M, Scattoni V, et al. PSA doubling time for prediction of [(11)C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy. Eur J Nucl Med Mol Imaging. 2010;37:1106-1116.
    • (2010) Eur J Nucl Med Mol Imaging. , vol.37 , pp. 1106-1116
    • Giovacchini, G.1    Picchio, M.2    Scattoni, V.3
  • 14
    • 77955879588 scopus 로고    scopus 로고
    • [(18) F]-fluorocholine positron- emission/computed tomography for lymph node staging of patients with prostate cancer: Preliminary results of a prospective study
    • Poulsen MH, Bouchelouche K, Gerke O, et al. [(18) F]-fluorocholine positron- emission/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study. BJU Int. 2010; 106:639-644.
    • (2010) BJU Int. , vol.106 , pp. 639-644
    • Poulsen, M.H.1    Bouchelouche, K.2    Gerke, O.3
  • 15
    • 43049153221 scopus 로고    scopus 로고
    • Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time
    • Arlen PM, Bianco F, Dahut WL, et al. Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time. J Urol. 2008; 179:2181-2185.
    • (2008) J Urol , vol.179 , pp. 2181-2185
    • Arlen, P.M.1    Bianco, F.2    Dahut, W.L.3
  • 16
    • 34548259960 scopus 로고    scopus 로고
    • Methods of calculating prostatespecific antigen velocity
    • Connolly D, Black A, Murray LJ, et al. Methods of calculating prostatespecific antigen velocity. Eur Urol. 2007;52:1044-1050.
    • (2007) Eur Urol , vol.52 , pp. 1044-1050
    • Connolly, D.1    Black, A.2    Murray, L.J.3
  • 17
    • 31544463834 scopus 로고    scopus 로고
    • Inadequacies of the current American Joint Committee on Cancer staging sytem for prostate cancer
    • DOI 10.1002/cncr.21605
    • Taylor SH, Merriman KW, Spiess PE, et al. Inadequacies of the current American Joint Committee on cancer staging system for prostate cancer. Cancer. 2006;106:559-565. (Pubitemid 43157618)
    • (2006) Cancer , vol.106 , Issue.3 , pp. 559-565
    • Taylor, S.H.1    Merriman, K.W.2    Spiess, P.E.3    Pisters, L.4
  • 18
    • 3042727071 scopus 로고    scopus 로고
    • Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy
    • DAmico AV, Chen MH, Roehl KA, et al. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med. 2004;351:125-135.
    • (2004) N Engl J Med , vol.351 , pp. 125-135
    • Damico, A.V.1    Chen, M.H.2    Roehl, K.A.3
  • 19
    • 34147137270 scopus 로고    scopus 로고
    • Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: A report from search
    • DOI 10.1016/j.urology.2007.01.019, PII S0090429507000209
    • King CR, Freedland SJ, Terris MK, et al. Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCH. Urology. 2007;69:732-737. (Pubitemid 46574938)
    • (2007) Urology , vol.69 , Issue.4 , pp. 732-737
    • King, C.R.1    Freedland, S.J.2    Terris, M.K.3    Aronson, W.J.4    Kane, C.J.5    Amling, C.L.6    Presti Jr., J.C.7
  • 20
    • 39149120824 scopus 로고    scopus 로고
    • Prostate specific antigen kinetics in the management of prostate cancer
    • Sengupta S, Amling C, DAmico AV, et al. Prostate specific antigen kinetics in the management of prostate cancer. J Urol. 2008;179:821-826.
    • (2008) J Urol , vol.179 , pp. 821-826
    • Sengupta, S.1    Amling, C.2    Damico, A.V.3
  • 23
    • 0028090544 scopus 로고
    • The clinical usefulness of prostate specific antigen: Update 1994
    • Partin AW, Oesterling JE. The clinical usefulness of prostate specific antigen: update 1994. J Urol. 1994;152:1358-1368. (Pubitemid 24326262)
    • (1994) Journal of Urology , vol.152 , Issue.5 , pp. 1358-1368
    • Partin, A.W.1    Oesterling, J.E.2
  • 24
    • 55649123911 scopus 로고    scopus 로고
    • PSA doubling time versus PSA velocity to predict high-risk prostate cancer: Data from the Baltimore Longitudinal Study of Aging
    • Loeb S, Kettermann A, Ferrucci L, et al. PSA doubling time versus PSA velocity to predict high-risk prostate cancer: data from the Baltimore Longitudinal Study of Aging. Eur Urol. 2008;54:1073-1080.
    • (2008) Eur Urol , vol.54 , pp. 1073-1080
    • Loeb, S.1    Kettermann, A.2    Ferrucci, L.3
  • 26
    • 0028787237 scopus 로고
    • Prostate-specific antigen variability in men without prostate cancer: Effect of sampling interval on prostatespecific antigen velocity
    • Carter HB, Pearson JD, Waclawiw Z, et al. Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostatespecific antigen velocity. Urology. 1995;45:591-596.
    • (1995) Urology , vol.45 , pp. 591-596
    • Carter, H.B.1    Pearson, J.D.2    Waclawiw, Z.3
  • 27
    • 0026755373 scopus 로고
    • Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease
    • Carter HB, Morrell CH, Pearson JD, et al. Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease. Cancer Res. 1992;52:3323-3328.
    • (1992) Cancer Res , vol.52 , pp. 3323-3328
    • Carter, H.B.1    Morrell, C.H.2    Pearson, J.D.3
  • 29
    • 39749180009 scopus 로고    scopus 로고
    • Long-term prediction of prostate cancer: Prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population
    • DOI 10.1200/JCO.2007.13.1490
    • Ulmert D, Serio AM, OBrien MF, et al. Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population. J Clin Oncol. 2008;26:835-841. (Pubitemid 351398073)
    • (2008) Journal of Clinical Oncology , vol.26 , Issue.6 , pp. 835-841
    • Ulmert, D.1    Serio, A.M.2    O'Brien, M.F.3    Becker, C.4    Eastham, J.A.5    Scardino, P.T.6    Bjork, T.7    Berglund, G.8    Vickers, A.J.9    Lilja, H.10
  • 30
    • 58549106592 scopus 로고    scopus 로고
    • Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer
    • Vickers AJ, Savage C, OBrien MF, et al. Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer. J Clin Oncol. 2009;27:398-403.
    • (2009) J Clin Oncol , vol.27 , pp. 398-403
    • Vickers, A.J.1    Savage, C.2    Obrien, M.F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.